At the time of writing, Sabra Healthcare REIT Inc [SBRA] stock is trading at $17.98, up 0.50%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SBRA shares have gain 1.30% over the last week, with a monthly amount glided 0.45%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sabra Healthcare REIT Inc [NASDAQ: SBRA] stock has seen the most recent analyst activity on October 01, 2025, when Cantor Fitzgerald initiated its Neutral rating and assigned the stock a price target of $20. Previously, Truist downgraded its rating to Hold on January 17, 2025. On January 07, 2025, upgrade upgraded it’s rating to Mkt Outperform but maintained its price target of $20 on the stock. Mizuho downgraded its rating to a Neutral but stick to its price target of $20 on December 05, 2024. Wells Fargo upgraded its rating to a Overweight and raised its price target to $20 on October 01, 2024. Citigroup upgraded its rating to Buy for this stock on September 13, 2024, and upped its price target to $20. In a note dated January 30, 2024, Deutsche Bank initiated a Buy rating and provided a target price of $21 on this stock.
For the past year, the stock price of Sabra Healthcare REIT Inc fluctuated between $15.60 and $19.99. Currently, Wall Street analysts expect the stock to reach $20.5 within the next 12 months. Sabra Healthcare REIT Inc [NASDAQ: SBRA] shares were valued at $17.98 at the most recent close of the market. An investor can expect a potential return of 14.02% based on the average SBRA price forecast.
Analyzing the SBRA fundamentals
According to Sabra Healthcare REIT Inc [NASDAQ:SBRA], the company’s sales were 724.83M for trailing twelve months, which represents an 5.85% jump. Gross Profit Margin for this corporation currently stands at 0.69% with Operating Profit Margin at 0.37%, Pretax Profit Margin comes in at 0.25%, and Net Profit Margin reading is 0.25%. To continue investigating profitability, this company’s Return on Assets is posted at 0.03, Equity is 0.07 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.65.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 17.60 points at the first support level, and at 17.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 18.57, and for the 2nd resistance point, it is at 19.16.
Ratios To Look Out For
It is important to note that Sabra Healthcare REIT Inc [NASDAQ:SBRA] has a current ratio of 0.89. Further, the Quick Ratio stands at 0.89, while the Cash Ratio is 0.05. Considering the valuation of this stock, the price to sales ratio is 5.95, the price to book ratio is 1.59 and price to earnings (TTM) ratio is 23.65.
Transactions by insiders
Recent insider trading involved FOSTER MICHAEL J, Director, that happened on May 20 ’25 when 11000.0 shares were sold. Director, Michael J. Foster completed a deal on May 15 ’25 to buy 11000.0 shares. Meanwhile, Director Cusack Catherine bought 1500.0 shares on Feb 24 ’25.
